Learning Resources Database

Welcome to the REMEDi4ALL learning resources database.

We have compiled this list to help you find key resources for training and learning in the drug repurposing space. There’s something for everyone regardless of your background and whether you’ve got 30 minutes to spare or a week to dive deep.

While additional resources are being built, please make use of what’s already out there.

Find exactly what you’re looking for by filtering based on the target audience and using the icons to identify delivery method, duration, cost, and digital accessibility score. Check out the short descriptions to see if it’s the right resource for you.

Do you know of other training resources relevant to the drug repurposing community? Please let us know by sending an email to training@remedi4all.org and we’ll include it.

Can’t find anything that meets your learning needs? We are currently developing more training resources, please get in touch at training@remedi4all.org and we will do our best to build something that’ll help you out.

Please note that the Digital Accessibility score is an approximate measure of how user-friendly each website is for people who use screen readers, keyboard-only navigation, or have other accessibility needs. They are not a score of the quality of the resource. 5 means no issues were identified while 1 indicates navigation could be very challenging for someone using assistive technology.

Filter by

Target Audiences








14 Result(s)

Webinar

Drug repurposing approaches to fast-track the development of new therapies for COVID-19

 
Lead organisationTECAN
Target audienceAcademicsIndustryProfessionalsResearchers
AvailabilityAlways available
CostsFree
Digital Accessibility3 - Decent

This 1-hour webinar focuses on how drug repurposing can be applied to COVID-19. It offers a relatively technical overview of how a repurposing candidate can be identified by comparing the mechanism of COVID-19 to other diseases with known drugs. While pitched toward academics and researchers, the webinar is a useful tool for anyone wishing to explore the process of repurposing from a scientific perspective.

Visit resource website

Webinar

Intro to drug repurposing for rare diseases

 
Lead organisationEJPRD, Eatris
Target audienceProfessionalsResearchersStudents
AvailabilityAlways available
CostsFree
Digital Accessibility4 - Good

This 2-hour webinar is aimed at students, researchers, and professionals. The first hour introduces a range of repurposing strategies including screening, computational docking, and using electronic health records, while the second looks at the importance of collaborating with patients through a range of case studies.

Visit resource website

Webinar

Repurposing TIN Seminar: Lessons Learnt in Drug Repurposing

 
Lead organisationUniversity College London
Target audienceProfessionalsResearchersStudents
AvailabilityAlways available
CostsFree
Digital Accessibility4 - Good

This 90-minute webinar offers insights from 4 experts about their experiences of drug repurposing, its challenges, and advice for others starting out. The case-study-based approach gives a feel for the real-world ups and downs. It is designed for researchers and professionals but could be helpful to students and patient groups too.

Visit resource website

In-Person

TMEX – Translational Medicine Explained

 
Lead organisationEatris
Target audienceAcademicsResearchers
AvailabilityFixed 5 day duration (annual)
Costs€650, discounts avaliable
Digital Accessibility4 - Good

This annual 5-day in-person course is designed for PhD and MD students wanting to learn more about translational medicine. TMex covers a range of topics from elevator pitches and regulations to clinical trials and personalized medicine. The course costs €650 but discounts are available for students part of specific projects.

Visit resource website

In-Person

EURORDIS Open Academy Schools

 
Lead organisationEURORDIS
Target audiencePatient Groups
AvailabilityFixed 5 day duration (annual)
CostsFree
Digital Accessibility5 - Great

These 5-day face-to-face residentials take place annually in Barcelona. There are two programmes to choose from focussing on either research and development or innovation and translation. Sessions are designed to empower rare disease patient advocates to engage with research and industry stakeholders as equals. Sessions are taught in English and some online prior learning is required. Accommodation and some food costs are covered and fellowships are available to assist with travel costs.

Visit resource website

Online course

EURORDIS Open Academy

 
Lead organisationEURORDIS
Target audiencePatient Groups
AvailabilityAlways available
CostsFree
Digital Accessibility5 - Great

The Open Academy provides free e-learning packages specifically designed to support patient groups and advocates through drug repurposing. Topics include patient registries, genome editing, and using statistics in research. Courses take around 2 to 5 hours to complete and on some, you can earn a certificate of completion. 

Visit resource website

Online course

Introduction to Translational research for Rare Diseases

 
Lead organisationEJPRD
Target audienceAcademicsPatient GroupsPatientsResearchers
AvailabilityFixed, 5 week duration
CostsFree
Digital Accessibility5 - Great

This free, 5-week online course teaches the fundamentals of getting an idea to a patient, specifically looking at the process for rare diseases. Topics include translational science, clinical trails, and marketing. The learning each week takes around 4 hours and consists of articles, videos, and quizzes.

Visit resource website

Online course

Clinical Pharmacokinetics: Dosing and Monitoring

 
Lead organisationTaipei Medical University
Target audienceAcademicsResearchers
AvailabilityAlways available
CostsFixed, 6 week duration
Digital Accessibility5 - Great

With 2 hours of study time each week for 6 weeks, this course introduces clinical pharmacokinetics, i.e. how drugs are absorbed, distributed, metabolized, and excreted in the body, and how to determine the right dose. The course is aimed at pharmacy students but is a great introduction to anyone wanting to learn about how drugs get processed and dosed.

Visit resource website

Online courseWebinar

Beacon: For Rare Disease Rescources Hub

 
Lead organisationBeacon
Target audiencePatient GroupsPatients
AvailabilityAlways available
CostsFree
Digital Accessibility4 - Good

With over 50 short courses and webinars, this is the perfect place for patient groups and advocates to start their repurposing journey. Topics include working with industry, health economics, and growing your patient community. Their introduction to drug repurposing course is a great way to get to grips with the process and explore case studies of repurposed drugs for rare diseases.

Visit resource website

Tool kit

Orphan Drug Development Guidebook – START Checklist

 
Lead organisationIRDiRC
Target audienceAcademicsIndustryResearchers
AvailabilityAlways available
CostsFree
Digital Accessibility3 - Decent

This online guide provides a framework for researchers to help navigate orphan drug development offering detailed charts of the regulatory processes in Europe, the US, and Japan. ‘Building block’ fact sheets summarise key concepts, organizations, and tools involved in drug development. Milestones show the stages a project needs to reach with checklists for what to do before and after each milestone. This video (https://www.youtube.com/watch?v=rXb8fDxE8Nk) introduces the guide in detail and has a helpful walkthrough of the website starting at 50.46.

Visit resource website

Tool kit

Innovation Management Toolbox

 
Lead organisationEJPRD
Target audienceAcademicsResearchers
AvailabilityAlways available
CostsFree
Digital Accessibility4 - Good

This reference library provides a deeper look into a range of repurposing topics. Browse by topic to find the resources relevant to you and simply click to be taken to the PDF, video, or website. Don’t forget to use the Q&A and ‘use cases’ sections too. Many of the resources are designed for researchers and academics.

Visit resource website

Tool kit

ROADMAP – Repurposing Of All Drugs, Mapping All Paths

 
Lead organisationEverycure
Target audienceAcademicsPatient GroupsResearchers
AvailabilityAlways available
CostsFree
Digital Accessibility3 - Decent

This rare disease-focused interactive roadmap takes users through the steps of drug repurposing as well as the roadblocks, resources, and stakeholders involved. It is based on a detailed survey of patients, researchers, and doctors and mostly focuses on repurposing FDA-approved drugs. Enjoy the map graphics and accessible English but please note, it requires a larger screen to be viewed. The site also offers an accessible PFD version.

Visit resource website

Tool kit

Medicines Repurposing Toolkit

 
Lead organisationLifeArc
Target audienceAcademicsPatient GroupsResearchers
AvailabilityAlways available
CostsFree
Digital Accessibility4 - Good

This tool kit offers a walk-through of the key phases of drug repurposing, covering target product profiles, preclinical discovery and development, clinical development, regulations, and funding. It’s a great place to start if you’re looking to understand the overall picture and start asking questions you didn’t know you had.

Visit resource website

REMEDi4ALL Partners & Associated partners

Anticancer Fund (ACF) - Belgium
FIMM Institute for Molecular Medicine Finland
University of Helsinki
Istituto Ortopedico Rizzoli (IOR) - Italy
Bundesinstitut Fur Arzneimittel Und Medizinprodukte (BFARM) - Germany
Dompé farmaceutici Spa (DOMPÉ) – Italy
EATRIS (Coordinator) – The Netherlands
Fraunhofer-Gesellschaft – Germany
University Of Hull (UHULL) – United Kingdom
Istituto Di Ricerche Farmacologiche Mario Negri (IRFMN) - Italy
Karolinska Institutet (KI) - Sweden
The University Of Sheffield (USFD) - United Kingdom
Universitaetsmedizin Goettingen (UMG) - Germany
Uppsala Universitet (UU) - Sweden
Beacon: For Rare Diseases (BEACON) - United Kingdom
European Clinical Research Infrastructure Network (ECRIN) - France
European Organisation For Rare Diseases Association (EURORDIS) – France
Istituto Nazionale Tumori Fondazione Pascale (INT-NA) - Italy
Medicines For Europe (M4EU) - Belgium
Servicio Madrileño De Salud (SERMAS) - Spain
Syreon Kutato Intezet Korlatolt Felelossegu Tarsasag (SRI) - Hungary
Univerza V Ljubljani - Slovenia
ZonMw (Zorgonderzoek Nederland Zon) (ZONMW) - Netherlands